Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02339662
Other study ID # gbvsam001-HMO-CTIL
Secondary ID
Status Recruiting
Phase Phase 4
First received December 14, 2014
Last updated October 18, 2015
Start date February 2015
Est. completion date January 2017

Study information

Verified date October 2015
Source Hadassah Medical Organization
Contact Doron J Aframian, DMD, PhD
Phone 972-2-677-6140
Email Dorona@hadassah.org.il
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of the study is comparing two drugs efficacy for the treatment of pain originates from masticatory muscles. The two drugs are - Amitriptlyne (amitriptyline) and Gabapentin (gabapentin), both of them are common use in for the treatment of chronic pain Methods - patient that is diagnosed as suffering from myofacial pain, will receive one of the medications above (Gabapentin or amitriptyline) for one month only, after which he will be invited to pain clinic for control. Two weeks after that, the patient will start taking the other drug for 1 month and then invited again to the department for recall and continue standard treatment . The patient can choose whether to continue medication with one of the drugs or stop this medication treatment. Total duration of the experiment is two and a half months.


Description:

Read more »
Read more »

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Gabapentin
muscles pain treatment
Amitriptyline
muscles pain treatment

Locations

Country Name City State
Israel Hadassah MO Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Doron Aframian

Country where clinical trial is conducted

Israel, 

References & Publications (13)

See more »

Outcome

Type Measure Description Time frame Safety issue
Primary pain decrease pain scale measuring 6 weeks No
Secondary The frequency of use of other drugs breacking drugs registration 6 weeks No
Secondary Improving function - open mouth, free jaw movement opening mouth measurement 6 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT06051799 - Effects of Pressure Release of Myofascial Trigger Points on Mechanical Neck Pain. N/A
Completed NCT04568915 - Dry Needling and Maitland Joint Mobilization Techniques in Patients With Myofacial Chronic Neck Pain N/A
Recruiting NCT04640896 - Trigger Point Injections in Anterior Cervical Surgery Phase 4
Recruiting NCT05619380 - Effectiveness of Physiotherapy Treatments in Temporomandibular Joint Dysfunction N/A
Recruiting NCT05151510 - Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department Phase 4
Completed NCT05358730 - Effects of IASTM in the Treatment of Adhesive Capsulitis N/A
Enrolling by invitation NCT05673655 - Intraoral Injection of Trigger Points by Botox Phase 2
Completed NCT01118988 - Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents N/A
Completed NCT04298554 - Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region N/A
Completed NCT05228327 - Occlusal Splint and Masticatory Muscle Injection in Myofacial Pain N/A
Recruiting NCT06358326 - Dry Needling and Rehabilitatin Carpal Tunnel Syndrome N/A
Completed NCT00690625 - Topical Application of MyoRx (Omega 3 Fatty Acids Containing) Cream Phase 1
Completed NCT00588432 - Characterization of Skeletal Muscle Using Magnetic Resonance Elastography (MRE) N/A